Аннотация
Девитализирующая обработка имплантируемых собакам ксенографтов при сроках наблюдения 4 месяца обеспечивает хороший антикальциевый эффект и не препятствует образованию неоинтимы на внутренней поверхности ксеноимплантата. Реакции острого отторжения имплантата не происходило, однако после эксплантации имелись признаки инфильтрации иммунокомпетентыми клетками и дегенерации девитализированной ксеноткани.
Литература
1. Акатов В. С., Соловьев В. В., Рындина Н. И. и др. Кальцификация бесклеточных ксенотрансплантатов клапанов сердца // Вест. трансплант. и искусств. органов. - 2002. - № 4. - С. 39-42.
2. Bader A., Schilling T., Teebken O. E. et al. Tissue engineering of heart valves - human endothelial cell seeding of detergent acellularized porcine valves // Eur. J. Cardiothorac. Surg. - 1998. - Vol. 14. - P. 279-284.
3. Bechtel J. F. M., Bartels C., Schmidtke C. et al. Anti- HLA class I antibodies and pulmonary homograft function after the Ross-procedure // Ann. Thorac. Surg. - 2001. - Vol. 71. - P. 2003-2007.
4. Bertiplaglia B., Ortolani F., Petrelli L. et al. Cell characterization of porcine aortic valve and decellularized leaflets repopulated with aortic valve interstitial cells: the VESALIO project (Vitalitate Exornatum Succedaneum Aorticum Labore Ingenioso Obtenibitur // Ibid. - 2003. - Vol. 75. - P. 1274-1282.
5. Booth C., Korossis S. A., Wilcox H. E. et al. Tissue engineering of cardiac valve prostheses I: Development and histological characterization of an acellular porcine scaffold // J. Heart Valve Dis. - 2002. - Vol. 11. - P. 457-462.
6. Curtil A., Pegg D. E., Wilson A. Repopulation of freeze-dried porcine valves with human fibroblasts and endothelial cells // Ibid. - 1997. - Vol. 6. - P. 296-306.
7. Da Costa A., Diniz F., Dohmen Pascal Maria et al. Immunological and echocardiographic evaluation of decellularized versus cryopreserved allografts during the Ross operation // Eur. J. Cardiothorac. Surg. - 2005. - Vol. 27. - P. 572-578.
8. Dignan R., OBrien M., Hogan P. et al. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leucocyte antigens // J. Heart Valve Dis. - 2003. - Vol. 12. - P. 382-391.
9. Dohmen M. P., Lembcke A., Dushe S. et al. Two years performance of a decellularized porcine pulmonary heart valve // Interact. Cardiovasc. Thorac. Surg. - 2006. - Vol. 5. - P. C10-17. - Abstracts: Suppl. 1.
10. Forbess J. M., Shah A. S. et al. Cryopreserved homografts in the pulmonary position: determinants of durability // Ann. Thorac. Surg. - 2001. - Vol. 71. - P. 54-59.
11. Kasimir M. T., Rieder E., Seebacher G. et al. Comparison of different decellularization procedures of porcine heart valves // Int. J. Artif. Organs. - 2003. - Vol. 26. - P. 421-427.
12. Kim W. G., Park J. K., Lee W. Y. Tissue-engineered heart valve leaflets: An effective method of obtaining acellularized valve xenografts // Ibid. - 2002. - Vol. 25. - P. 791-797.
13. Leyh R. G., Wilhelmi M., Rebe P. et al. In vivo repopulation of xenogeneic and allogeneic acellular valve matrix conduits in the pulmonary circulation // Ann. Thorac. Surg. - 2003. - Vol. 75. - P. 1457-1463.
14. Pompilio G., Polvani G., Piccolo G. et al. Six-year monitoring of the donor-specific immune response to cryopreserved aortic allograft valves: implications with valve dysfunction // Ibid. - 2004. - Vol. 78. - P. 557-563.
15. Schoen F. J., Levy R. J. Tissue heart valves: Current challenges and future research perspectives. Founders award 25th annual meeting of the society for biomaterials, Providence, RI, April 28-May 2 // J. Biomed. Mater. Res. - 1999. - Vol. 47. - P. 439-465.
16. Senthilnathan V., Treasure T., Grunkemeier G., Starr A. Heart valves: which is the best choice? // Cardiovasc. Surg. - 1999. - Vol. 7. - P. 393-397.
17. Simon P., Kasimir M. T., Seebacher G. et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients // Eur. J. Cardiothorac. Surg. - 2003. - Vol. 23. - P. 1002-1006.
18. Steinhoff G., Stock U., Karim N. et al. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits // Circulation. - 2000. - Vol. 102, № 19 (Suppl. III). - P. III50-III55.
19. Tavakkol Z., Gelehrter S., Goldberg C. S. et al. Superior durability of synergraft pulmonary allografts compared with standard cryopreserved allografts // Ann. Thorac. Surg. - 2005. - Vol. 80. - P. 1610-1614.
20. Zeltinger J., Landeen L. K., Alexander H. G. et al. Development and characterization of tissue-engineered aortic valves // Tissue Eng. - 2001. - Vol. 7. - P. 9-22.
